Ambulatory Blood Pressure Monitoring Devices Global Market Report 2025

The ambulatory blood pressure monitoring devices market size has grown rapidly in recent years. It will grow from $1.03 billion in 2024 to $1.15 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth during the historic period can be attributed to the rising prevalence of hypertension, growing awareness of cardiovascular health, increased adoption of home healthcare technologies, higher demand for continuous blood pressure monitoring, and an increased emphasis on early diagnosis and management.

The ambulatory blood pressure monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $1.78 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to the increasing integration of wearable technology, growing adoption of telemedicine, rising demand for personalized healthcare, increased investments in healthcare infrastructure, and the escalating prevalence of chronic diseases. Key trends expected during this period include advancements in wireless technology, improved sensor accuracy, innovations in data analytics, integration with mobile health applications, and the development of compact, user-friendly devices.

The rising prevalence of hypertension is expected to drive the growth of the ambulatory blood pressure monitoring devices market moving forward. Hypertension is a condition marked by consistently elevated blood pressure levels in the arteries. Its increasing occurrence is fueled by factors such as unhealthy diets, sedentary lifestyles, and rising obesity rates. Ambulatory blood pressure monitoring devices assist in managing hypertension by providing continuous and accurate blood pressure measurements during daily activities and sleep, allowing for improved diagnosis and personalized treatment. For example, in September 2023, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that hypertension affects one in three adults globally (approximately 1.3 billion people), and increasing effective treatment coverage to 50% by 2025 could prevent 76 million deaths by 2050. Thus, the growing prevalence of hypertension is anticipated to boost the ambulatory blood pressure monitoring devices market.

Major companies operating in the ambulatory blood pressure monitoring devices market are focusing on technological advancements such as point-of-care devices to improve real-time monitoring accuracy, enhance patient comfort, and enable quicker clinical decision-making. A point-of-care device is a medical instrument used at or near the patient’s location to deliver rapid diagnostic or monitoring results without the need for a centralized laboratory. For example, in July 2022, CardiAI Inc., a Canada-based biotechnology firm, launched BPAro, an advanced 24-hour ambulatory blood pressure monitor. This device supports continuous monitoring for up to seven days, collecting blood pressure data during daily activities and sleep. It features Bluetooth connectivity, allowing real-time data sharing with both patients and healthcare providers. BPAro is designed for ease of use, improving convenience and comfort while supporting better hypertension detection and management outside traditional clinical settings.

In November 2022, CardieX Limited, an Australia-based health technology company, acquired Blumio, Inc. for an undisclosed sum. The acquisition aims to advance continuous, non-invasive monitoring of blood pressure and arterial health, supporting CardieX’s mission to lead in next-generation ambulatory blood pressure monitoring (ABPM) technology. Blumio, Inc., based in the US, specializes in developing wearable, non-contact millimeter-wave radar sensors for ambulatory blood pressure monitoring.

Major players in the ambulatory blood pressure monitoring devices market are Koninklijke Philips N.V. (Philips Healthcare), GE Healthcare Technologies Inc., Omron Healthcare Co. Ltd., Hill-Rom Holdings Inc., Halma plc, OSI Systems Inc., Contec Medical Systems Co. Ltd., Spacelabs Healthcare Inc., Schiller Holding AG, Withings S.A. (Withings Inc.), Vaso Corporation, BPL Medical Technologies Private Limited, Microlife Corporation (Microlife AG), SunTech Medical Inc., Rossmax International Ltd., Rudolf Riester GmbH, iHealth Labs Inc., American Diagnostic Corporation, AViTA Corporation, Bosch + Sohn GmbH u. Co. KG.

North America was the largest region in the ambulatory blood pressure monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ambulatory blood pressure monitoring devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ambulatory blood pressure monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Ambulatory blood pressure monitoring (ABPM) devices are medical instruments designed to continuously measure blood pressure over a 24-hour period while the patient engages in their regular daily activities. These devices generally include a cuff and a digital recorder worn on the body. They offer more accurate and comprehensive blood pressure data compared to single-point measurements. ABPM is particularly valuable for diagnosing conditions such as white-coat hypertension and nocturnal hypertension.

The main types of ambulatory blood pressure monitoring devices include automatic ABPM devices, manual ABPM devices, and specialized ABPM devices. Automatic ABPM devices automatically record blood pressure at set intervals throughout the 24-hour period without the need for manual input. Device categories include ambulatory blood pressure monitors, home blood pressure monitors, hospital blood pressure monitors, wearable blood pressure monitors, and finger blood pressure monitors. These devices are used in hypertension management, cardiovascular disease monitoring, preoperative assessment, and postoperative monitoring. They are distributed through various channels such as direct sales, online retail, third-party distributors, and pharmacies. The primary end users include hospitals, homecare providers, prescription users, and over-the-counter (OTC) consumers.

The ambulatory blood pressure monitoring devices market research report is one of a series of new reports that provides ambulatory blood pressure monitoring devices market statistics, including the ambulatory blood pressure monitoring devices industry global market size, regional shares, competitors with the ambulatory blood pressure monitoring devices market share, detailed ambulatory blood pressure monitoring devices market segments, market trends, and opportunities, and any further data you may need to thrive in the ambulatory blood pressure monitoring devices industry. This ambulatory blood pressure monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ambulatory blood pressure monitoring devices market consists of revenues earned by entities by providing services such as tele monitoring services, clinical research support services, integration and it support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ambulatory blood pressure monitoring (abpm) devices market includes sales of bluetooth-enabled abpm devices, programmable abpm devices, and digital abpm devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.